Horizon Discovery (a Revvity company)
Is this your company? Claim this profile
Advanced Modalities
Analytical & Bioanalytical Services
Company Overview
About
Horizon Discovery (a Revvity company) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Neurology
Quick Facts
HQ:United Kingdom
Founded:2014
Employees:2,413
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval TUT9ZQ
Health Canada · #APR-9NVI5Y7K · 2019-04-01
Certifications
WHO GMP
World Health Organization
Cert #: CERT-XM98TMB7
Issued: 2020-11-16
Expires: 2025-09-26
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-UKZCWWHW
Issued: 2020-09-16
Expires: 2025-02-21
Health Canada GMP
Health Canada
Cert #: CERT-7SLCZZYR
Issued: 2020-11-17
Expires: 2025-03-06
Loading CDMO intelligence...
Key facts about Horizon Discovery (a Revvity company)
- Horizon Discovery (a Revvity company) is headquartered in the United Kingdom.
- Horizon Discovery (a Revvity company) was founded in 2014.
- Horizon Discovery (a Revvity company) has 2,413 employees.
- Horizon Discovery (a Revvity company)'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like Horizon Discovery (a Revvity company)
Directory pages this company appears in, each with the full list of matching manufacturers.